VI-DOM-A Drug Patent Profile
✉ Email this page to a colleague
When do Vi-dom-a patents expire, and when can generic versions of Vi-dom-a launch?
Vi-dom-a is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in VI-DOM-A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VI-DOM-A?
- What are the global sales for VI-DOM-A?
- What is Average Wholesale Price for VI-DOM-A?
Summary for VI-DOM-A
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Patent Applications: | 2,346 |
DailyMed Link: | VI-DOM-A at DailyMed |
US Patents and Regulatory Information for VI-DOM-A
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | VI-DOM-A | vitamin a palmitate | CAPSULE;ORAL | 080972-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |